A Replication-Limited Recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG. (Q36950010)
Jump to navigation
Jump to search
scientific article published on 25 August 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Replication-Limited Recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG. |
scientific article published on 25 August 2008 |
Statements
1 reference
A Replication-Limited Recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG. (English)
1 reference
Mycobacterium bovis
1 reference
Michael V Tullius
1 reference
Günter Harth
1 reference
Sasa Maslesa-Galic
1 reference
Barbara J Dillon
1 reference
Marcus A Horwitz
1 reference
25 August 2008
1 reference
1 reference
5200-5214
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference